The impact of race and HLA matching on long-term survival following cardiac transplantation.
Park
M H
MH
Medical College of Virginia Hospital, Richmond, VA 23298-0005, USA.
Tolman
D E
DE
Kimball
P M
PM
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D044383:Black People; D016572:Cyclosporine / Q000627:therapeutic use; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D044469:Racial Groups; D012189:Retrospective Studies; D015996:Survival Rate; D014481:United States; D044465:White People; D001741:Black or African American
D000961:Antilymphocyte Serum; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine